Search Results 1711-1720 of 18766 for Activation

  1. Clinical trials - Oncology (Medical)

    ... activation and exhaustion. A Study to Evaluate the Incidence and Psychological Impact of Vaginal Cuff Dehiscence After Different Types of Hysterectomy.

  2. A Study to Assess the Safety and Dose Escalation of Pegtomarginase (PT01) for Subjects with Advanced Malignancies - Mayo Clinic

    Prothrombin time (PT) (or International Normalized Ratio [INR]) and activated partial thromboplastin time (aPTT) ≤ 1.5 × ULN or within the intended ...

  3. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

    collection). 10. Prothrombin time ≤ 1.5 × ULN (or international normalization ratio [INR] ≤ 1.3) and partial thromboplastin time (PTT) or activated partial ...

  4. Publications - Allison C. Rosenthal, D.O. - Mayo Clinic

    Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1). J Allergy Clin Immunol Glob. 2025 Aug; 4 (3): ...

  5. Long COVID: Lasting effects of COVID-19 - Mayo Clinic

    Mast cell activation syndrome. Fibromyalgia. Diabetes. Hyperlipidemia. People can get long COVID symptoms after catching the COVID-19 virus even if they ...

  6. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    International normalized ratio (INR) and activated prothrombin time (aPTT) ≤ 1.5 ULN unless the patient is receiving anticoagulation therapy and INR and ...

  7. Clinical trials - Oncology (Medical)

    ... activation and exhaustion. A Study to Evaluate the Incidence and Psychological Impact of Vaginal Cuff Dehiscence After Different Types of Hysterectomy.

  8. Publications - Fiona E. Craig, M.D. - Mayo Clinic

    Does hyperconcentration result in platelet activation? A flow-cytometric study of hyperconcentrated random donor platelets. Vox Sang. 1998; 75(2):124-7 ...

  9. Clinical trials - Oncology (Medical)

    We present here a CAR design that allows PD-1 to recognize PD-L1 on the tumor; however, the intracellular CAR design is one that results in T cell activation as ...

  10. Clinical trials - Oncology (Medical)

    Fibroblast activation protein (FAP) is a cell surface protein that is highly expressed on the surface of cancer-associated fibroblasts (CAFs) present in the ...